ImportRefusal LogoImportRefusal

Les Importations Herbasante Inc.

⚠️ High Risk

FEI: 3003175217 • Saint-Laurent, Quebec • CANADA

FEI

FEI Number

3003175217

📍

Location

Saint-Laurent, Quebec

🇨🇦

Country

CANADA
🏢

Address

377 Sainte-Croix Ave, , Saint-Laurent, Quebec, Canada

High Risk

FDA Import Risk Assessment

62.0
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

30
Total Refusals
6
Unique Violations
4/21/2025
Latest Refusal
4/8/2010
Earliest Refusal

Score Breakdown

Violation Severity
65.9×40%
Refusal Volume
55.2×30%
Recency
85.5×20%
Frequency
19.9×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

2727×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

33613×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

23001×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

2561×

INCONSPICU

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

38621×

DIETARYING

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(A) of the FD&C Act in that the dietary supplement label or labeling fails to list the name of each dietary ingredient of the supplement and the quantity of each such dietary ingredient or , with respect to a proprietary blend of such dietary ingredients, the total quantity of all dietary ingredients in the blend.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
4/21/2025
41YYY99DIETARY CONVENTIONAL FOODS, N.E.C.
27DRUG GMPS
Division of Southeast Imports (DSEI)
3/26/2025
54YCY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
2300DIETARYLBL
3862DIETARYING
Division of Northern Border Imports (DNBI)
6/30/2021
61XBQ99ANTI-HISTAMINIC N.E.C.
27DRUG GMPS
336INCONSPICU
Division of Northern Border Imports (DNBI)
6/30/2021
61XBQ99ANTI-HISTAMINIC N.E.C.
27DRUG GMPS
336INCONSPICU
Division of Northern Border Imports (DNBI)
6/30/2021
61WBQ99A-FUNGAL N.E.C.
27DRUG GMPS
336INCONSPICU
Division of Northern Border Imports (DNBI)
6/30/2021
65RBQ99REPLENISHER N.E.C.
27DRUG GMPS
336INCONSPICU
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
336INCONSPICU
Division of Northern Border Imports (DNBI)
6/30/2021
60ZBQ99ANTIPARASITIC, N.E.C.
27DRUG GMPS
336INCONSPICU
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
336INCONSPICU
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
336INCONSPICU
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
336INCONSPICU
Division of Northern Border Imports (DNBI)
6/30/2021
61XBQ99ANTI-HISTAMINIC N.E.C.
27DRUG GMPS
336INCONSPICU
Division of Northern Border Imports (DNBI)
6/30/2021
62GBQ99ANTI-INFLAMMATORY N.E.C.
27DRUG GMPS
336INCONSPICU
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
336INCONSPICU
Division of Northern Border Imports (DNBI)
6/30/2021
61WBQ99A-FUNGAL N.E.C.
27DRUG GMPS
336INCONSPICU
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
Division of Northern Border Imports (DNBI)
6/30/2021
60CBQ99ADRENERGIC N.E.C.
27DRUG GMPS
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
Division of Northern Border Imports (DNBI)
6/30/2021
61KBQ06BELLADONNA (EXT) (ANTI-CHOLINERGIC)
27DRUG GMPS
Division of Northern Border Imports (DNBI)
6/30/2021
61XBQ99ANTI-HISTAMINIC N.E.C.
27DRUG GMPS
Division of Northern Border Imports (DNBI)
6/30/2021
60ZBQ99ANTIPARASITIC, N.E.C.
27DRUG GMPS
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
Division of Northern Border Imports (DNBI)
6/30/2021
65CBQ99NUTRIENT/TONIC N.E.C.
27DRUG GMPS
Division of Northern Border Imports (DNBI)
2/25/2013
54YEY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
256INCONSPICU
New York District Office (NYK-DO)
4/8/2010
54YCY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
Minneapolis District Office (MIN-DO)

Frequently Asked Questions

What is Les Importations Herbasante Inc.'s FDA import refusal history?

Les Importations Herbasante Inc. (FEI: 3003175217) has 30 FDA import refusal record(s) in our database, spanning from 4/8/2010 to 4/21/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Les Importations Herbasante Inc.'s FEI number is 3003175217.

What types of violations has Les Importations Herbasante Inc. received?

Les Importations Herbasante Inc. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Les Importations Herbasante Inc. come from?

All FDA import refusal data for Les Importations Herbasante Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.